Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
| Revenue (Most Recent Fiscal Year) | $6.55B |
| Net Income (Most Recent Fiscal Year) | $-530.20M |
| PE Ratio (Current Year Earnings Estimate) | 11.00 |
| PE Ratio (Trailing 12 Months) | 9.51 |
| PEG Ratio (Long Term Growth Estimate) | 3.41 |
| Price to Sales Ratio (Trailing 12 Months) | 0.90 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.06 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 5.71 |
| Pre-Tax Margin (Trailing 12 Months) | -6.74% |
| Net Margin (Trailing 12 Months) | -8.09% |
| Return on Equity (Trailing 12 Months) | 10.45% |
| Return on Assets (Trailing 12 Months) | 5.06% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.78 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.18 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.70 |
| Inventory Turnover (Trailing 12 Months) | 5.61 |
| Book Value per Share (Most Recent Fiscal Quarter) | $8.16 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.22 |
| Earnings per Share (Most Recent Fiscal Year) | $0.90 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.78 |
| Exchange | NYSE |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Common Shares Outstanding | 682.06M |
| Free Float | 673.87M |
| Market Capitalization | $5.90B |
| Average Volume (Last 20 Days) | 11.96M |
| Beta (Past 60 Months) | 0.97 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.20% |
| Percentage Held By Institutions (Latest 13F Reports) | 95.08% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |